Dengue
Copyright © 2024 Elsevier Ltd. All rights reserved..
Dengue, caused by four closely related viruses, is a growing global public health concern, with outbreaks capable of overwhelming health-care systems and disrupting economies. Dengue is endemic in more than 100 countries across tropical and subtropical regions worldwide, and the expanding range of the mosquito vector, affected in part by climate change, increases risk in new areas such as Spain, Portugal, and the southern USA, while emerging evidence points to silent epidemics in Africa. Substantial advances in our understanding of the virus, immune responses, and disease progression have been made within the past decade. Novel interventions have emerged, including partially effective vaccines and innovative mosquito control strategies, although a reliable immune correlate of protection remains a challenge for the assessment of vaccines. These developments mark the beginning of a new era in dengue prevention and control, offering promise in addressing this pressing global health issue.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:403 |
---|---|
Enthalten in: |
Lancet (London, England) - 403(2024), 10427 vom: 17. Feb., Seite 667-682 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Paz-Bailey, Gabriela [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 19.02.2024 Date Revised 19.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/S0140-6736(23)02576-X |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM367707977 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM367707977 | ||
003 | DE-627 | ||
005 | 20240219232022.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240128s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/S0140-6736(23)02576-X |2 doi | |
028 | 5 | 2 | |a pubmed24n1299.xml |
035 | |a (DE-627)NLM367707977 | ||
035 | |a (NLM)38280388 | ||
035 | |a (PII)S0140-6736(23)02576-X | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Paz-Bailey, Gabriela |e verfasserin |4 aut | |
245 | 1 | 0 | |a Dengue |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 19.02.2024 | ||
500 | |a Date Revised 19.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2024 Elsevier Ltd. All rights reserved. | ||
520 | |a Dengue, caused by four closely related viruses, is a growing global public health concern, with outbreaks capable of overwhelming health-care systems and disrupting economies. Dengue is endemic in more than 100 countries across tropical and subtropical regions worldwide, and the expanding range of the mosquito vector, affected in part by climate change, increases risk in new areas such as Spain, Portugal, and the southern USA, while emerging evidence points to silent epidemics in Africa. Substantial advances in our understanding of the virus, immune responses, and disease progression have been made within the past decade. Novel interventions have emerged, including partially effective vaccines and innovative mosquito control strategies, although a reliable immune correlate of protection remains a challenge for the assessment of vaccines. These developments mark the beginning of a new era in dengue prevention and control, offering promise in addressing this pressing global health issue | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 7 | |a Vaccines |2 NLM | |
700 | 1 | |a Adams, Laura E |e verfasserin |4 aut | |
700 | 1 | |a Deen, Jacqueline |e verfasserin |4 aut | |
700 | 1 | |a Anderson, Kathryn B |e verfasserin |4 aut | |
700 | 1 | |a Katzelnick, Leah C |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Lancet (London, England) |d 1945 |g 403(2024), 10427 vom: 17. Feb., Seite 667-682 |w (DE-627)NLM000473936 |x 1474-547X |7 nnns |
773 | 1 | 8 | |g volume:403 |g year:2024 |g number:10427 |g day:17 |g month:02 |g pages:667-682 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/S0140-6736(23)02576-X |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 403 |j 2024 |e 10427 |b 17 |c 02 |h 667-682 |